These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22513347)

  • 1. Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.
    Smith LJ; Baldo G; Wu S; Liu Y; Whyte MP; Giugliani R; Elliott DM; Haskins ME; Ponder KP
    Mol Genet Metab; 2012 Sep; 107(1-2):153-60. PubMed ID: 22513347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs.
    Smith LJ; Martin JT; O'Donnell P; Wang P; Elliott DM; Haskins ME; Ponder KP
    Mol Genet Metab; 2012 Sep; 107(1-2):145-52. PubMed ID: 22510705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
    Bigg PW; Baldo G; Sleeper MM; O'Donnell PA; Bai H; Rokkam VR; Liu Y; Wu S; Giugliani R; Casal ML; Haskins ME; Ponder KP
    Mol Genet Metab; 2013 Nov; 110(3):319-28. PubMed ID: 23856419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VII.
    Smith LJ; Martin JT; Szczesny SE; Ponder KP; Haskins ME; Elliott DM
    J Orthop Res; 2010 May; 28(5):616-22. PubMed ID: 19918911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
    Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
    Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of vertebral bone disease in mucopolysaccharidosis VII dogs from birth to skeletal maturity.
    Peck SH; Lau YK; Kang JL; Lin M; Arginteanu T; Matalon DR; Bendigo JR; O'Donnell P; Haskins ME; Casal ML; Smith LJ
    Mol Genet Metab; 2021 Aug; 133(4):378-385. PubMed ID: 34154922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs.
    Chiaro JA; Baron MD; Del Alcazar CM; O'Donnell P; Shore EM; Elliott DM; Ponder KP; Haskins ME; Smith LJ
    Bone; 2013 Jul; 55(1):78-83. PubMed ID: 23563357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.
    Metcalf JA; Linders B; Wu S; Bigg P; O'Donnell P; Sleeper MM; Whyte MP; Haskins M; Ponder KP
    Mol Genet Metab; 2010 Apr; 99(4):396-407. PubMed ID: 20044292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.
    Peck SH; Tobias JW; Shore EM; Malhotra NR; Haskins ME; Casal ML; Smith LJ
    Bone; 2019 Nov; 128():115042. PubMed ID: 31442675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
    Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.
    Kantaputra PN; Smith LJ; Casal ML; Kuptanon C; Chang YC; Nampoothiri S; Paiyarom A; Veerasakulwong T; Trachoo O; Ketudat Cairns JR; Chinadet W; Tanpaiboon P
    Am J Med Genet A; 2019 Mar; 179(3):486-493. PubMed ID: 30653816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade.
    Bigg PW; Sleeper MM; O'Donnell PA; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
    Mol Genet Metab; 2013 Nov; 110(3):311-8. PubMed ID: 23860311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.
    Baldo G; Wu S; Howe RA; Ramamoothy M; Knutsen RH; Fang J; Mecham RP; Liu Y; Wu X; Atkinson JP; Ponder KP
    Mol Genet Metab; 2011 Dec; 104(4):608-19. PubMed ID: 21944884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
    Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
    Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiphyseal cartilage canal architecture and extracellular matrix remodeling in mucopolysaccharidosis VII dogs at the onset of postnatal growth.
    Jiang Z; Johnson CP; Nykänen O; Nissi M; Lau YK; Wu M; Casal ML; Smith LJ
    Connect Tissue Res; 2021 Nov; 62(6):698-708. PubMed ID: 33334202
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
    Gurda BL; De Guilhem De Lataillade A; Bell P; Zhu Y; Yu H; Wang P; Bagel J; Vite CH; Sikora T; Hinderer C; Calcedo R; Yox AD; Steet RA; Ruane T; O'Donnell P; Gao G; Wilson JM; Casal M; Ponder KP; Haskins ME
    Mol Ther; 2016 Feb; 24(2):206-216. PubMed ID: 26447927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs.
    Chiaro JA; O'Donnell P; Shore EM; Malhotra NR; Ponder KP; Haskins ME; Smith LJ
    J Bone Miner Res; 2014 Dec; 29(12):2610-7. PubMed ID: 24898323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical basis of the beta-glucuronidase gene defect causing canine mucopolysaccharidosis VII.
    Ray J; Scarpino V; Laing C; Haskins ME
    J Hered; 1999; 90(1):119-23. PubMed ID: 9987917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.
    Xing EM; Knox VW; O'Donnell PA; Sikura T; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
    Mol Genet Metab; 2013 Jun; 109(2):183-93. PubMed ID: 23628461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural analysis of different skeletal cell types in mucopolysaccharidosis dogs at the onset of postnatal growth.
    Jiang Z; Lau YK; Wu M; Casal ML; Smith LJ
    J Anat; 2021 Feb; 238(2):416-425. PubMed ID: 32895948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.